The generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Nebivolol is used alone or together with other medicines to treat high blood pressure
It is only the second generic application approved by the USFDA
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
The product will be manufactured at Lupin’s facility in Goa, India
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
The product will be manufactured at Lupin’s facility in Pithampur, India
Subscribe To Our Newsletter & Stay Updated
